会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • FLUID COMPONENT ANALYSIS SYSTEM AND METHOD FOR GLUCOSE MONITORING AND CONTROL
    • 流体组分分析系统和葡萄糖监测与控制方法
    • WO2011031351A1
    • 2011-03-17
    • PCT/US2010/033794
    • 2010-05-05
    • OPTISCAN BIOMEDICAL CORPORATIONRULE, Peter
    • RULE, Peter
    • A61B5/00
    • G10L21/0208A61M5/168A61M5/1723
    • Disclosed are methods and apparatuses for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment dose (e g insulin, dextrose, etc ) and provide glycemic control. The dose of the treatment drug may be based on the patient's calculated sensitivity to treatment dosing, for example. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte. Delivery of the treatment drug can be cut off if the determined analyte concentration indicates that continued delivery would be harmful to the patient.
    • 公开了用于测定诸如体液的样品中的分析物浓度的方法和装置。 本文公开的系统和方法还可以包括注射或注射治疗剂量(例如胰岛素,葡萄糖等)并提供血糖控制的治疗剂量系统。 治疗药物的剂量可以基于例如患者对治疗剂量的计算灵敏度。 治疗药物的剂量可以基于分析物的浓度或分析物浓度的平均值和/或分析物浓度值的变化率。 如果确定的分析物浓度表明持续传递对患者有害,则可以切断治疗药物的递送。